Benzinga | Nov 9, 2020 04:27PM EST

Homology Medicines Q3 EPS $(0.62) Up From $(0.67) YoY, Sales $567.00K Up From $441.00K YoY

Homology Medicines (NASDAQ:FIXX) reported quarterly losses of $(0.62) per share. This is a 7.46 percent increase over losses of $(0.67) per share from the same period last year. The company reported $567.00 thousand in sales this quarter. This is a 28.57 percent increase over sales of $441.00 thousand the same period last year.